We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+16.44%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$13.3B
AUM Growth
+$1.82B
Cap. Flow
+$65.9M
Cap. Flow %
0.5%
Top 10 Hldgs %
32.36%
Holding
350
New
21
Increased
125
Reduced
153
Closed
21

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$72.8M
2
ABBV icon
AbbVie
ABBV
+$59.8M
3
PG icon
Procter & Gamble
PG
+$53.3M
4
VZ icon
Verizon
VZ
+$26.4M
5
AVGO icon
Broadcom
AVGO
+$19.9M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$79.9M
2
MCD icon
McDonald's
MCD
+$64.5M
3
EL icon
Estee Lauder
EL
+$57.4M
4
O icon
Realty Income
O
+$20.5M
5
AAPL icon
Apple
AAPL
+$18.6M

Sector Composition

Rank Sector Weight
1 Technology 21.17%
2 Healthcare 15.36%
3 Financials 13.42%
4 Consumer Staples 9.92%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WM icon
76
Waste Management
WM
$91B
$20.2M 0.15%
190,847
+413
+0.2% +$41.7K
DIS icon
77
Walt Disney
DIS
$181B
$18.1M 0.14%
162,257
-34,030
-17% -$3.76M
TFX icon
78
Teleflex
TFX
$5.98B
$18.1M 0.14%
49,671
-2,127
-4% -$735K
FIBK icon
79
First Interstate BancSystem
FIBK
$3.58B
$17.9M 0.13%
579,113
-10,055
-2% -$307K
UPS icon
80
United Parcel Service
UPS
$88.9B
$17.5M 0.13%
157,816
+203
+0.1% +$20.3K
G icon
81
Genpact
G
$5.76B
$17.1M 0.13%
469,543
+31,587
+7% +$1.07M
CHD icon
82
Church & Dwight Co
CHD
$24.5B
$15.9M 0.12%
205,764
-1,677
-0.8% -$122K
EVR icon
83
Evercore
EVR
$11.8B
$15.1M 0.11%
255,925
+2,456
+1% +$134K
NVS icon
84
Novartis
NVS
$297B
$14.9M 0.11%
170,161
-4,373
-3% -$377K
RTX icon
85
RTX Corp
RTX
$301B
$13.8M 0.1%
224,599
-142,145
-39% -$8.87M
ENB icon
86
Enbridge
ENB
$112B
$13.5M 0.1%
445,183
-2,645
-0.6% -$81.3K
EMR icon
87
Emerson Electric
EMR
$88.3B
$13.4M 0.1%
215,758
-11,160
-5% -$634K
DGX icon
88
Quest Diagnostics
DGX
$26.3B
$13.2M 0.1%
116,128
-1,555
-1% -$165K
SYY icon
89
Sysco
SYY
$40.3B
$13.2M 0.1%
241,349
-18,198
-7% -$957K
EL icon
90
Estee Lauder
EL
$32B
$13.1M 0.1%
69,573
-321,159
-82% -$57.4M
HUBB icon
91
Hubbell
HUBB
$27.2B
$12.7M 0.1%
101,223
+3,861
+4% +$470K
UNP icon
92
Union Pacific
UNP
$174B
$12.5M 0.09%
73,851
+1,020
+1% +$163K
RMD icon
93
ResMed
RMD
$30.7B
$12.1M 0.09%
63,199
+320
+0.5% +$52.4K
ROP icon
94
Roper Technologies
ROP
$39.8B
$12M 0.09%
30,951
+85
+0.3% +$30.5K
CPT icon
95
Camden Property Trust
CPT
$11.3B
$11.3M 0.08%
123,421
+934
+0.8% +$82.6K
ADI icon
96
Analog Devices
ADI
$190B
$11M 0.08%
89,886
-1,588
-2% -$174K
TJX icon
97
TJX Companies
TJX
$178B
$10.9M 0.08%
216,091
-73,152
-25% -$3.67M
LCII icon
98
LCI Industries
LCII
$2.65B
$10.7M 0.08%
93,160
-271
-0.3% -$25K
SMG icon
99
ScottsMiracle-Gro
SMG
$3.66B
$10.6M 0.08%
79,134
+15,212
+24% +$1.96M
FAST icon
100
Fastenal
FAST
$59.5B
$9.93M 0.07%
463,420
-170,610
-27% -$3.26M

Similar funds

Bahl & Gaynor's Q2 2020 Portfolio in Review

As of Q2 2020, Bahl & Gaynor held 350 positions worth $13.3B, up 16% from $11.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor's Q2 2020 filing shows 21 new, 125 increased, 153 reduced and 21 closed positions. Its largest new stake was Otis Worldwide: 90,609 shares worth $5.15M. The largest sale was Pfizer, an estimated $79.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q2 2020 buy was Otis Worldwide: 90,609 shares worth $5.15M.
  • Bahl & Gaynor added most to Merck in Q2 2020, an estimated $72.8M increase.
  • Bahl & Gaynor's biggest Q2 2020 reduction was Pfizer, cutting an estimated $79.9M.
  • Bahl & Gaynor fully exited Interparfums in Q2 2020, selling an estimated $4.84M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $13.3B portfolio in Q2 2020.
  • Bahl & Gaynor opened 21 new positions and closed 21 in Q2 2020.
  • Bahl & Gaynor's portfolio value rose 16% quarter-over-quarter to $13.3B.

Based on Bahl & Gaynor's 13F filing for Q2 2020, filed 13 Aug 2020.